Beneficial effects of N,N,N-trimethylsphingosine following ischemia and reperfusion in the isolated perfused rat heart

Cardiovascular Research

Volumn 39, Issue 2, 1998, Pages 393-400

  Campbell, Barry ^a   Shin, Yong K ^a   Scalia, Rosario ^a   Lefer, Allan M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cell adhesion molecules; Myocardium; Neutrophils; NO electrode; Rat; Sphingosine

Indexed keywords

MYELOPEROXIDASE; N,N,N TRIMETHYLSPHINGOSINE; NITRIC OXIDE; SPHINGOSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME ACTIVITY; HEART CONTRACTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; LEUKOCYTE ADHERENCE INHIBITION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA; DISEASE MODELS, ANIMAL; ELECTRODES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHILS; NITRIC OXIDE; PERFUSION; PEROXIDASE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SPHINGOSINE; VENTRICULAR FUNCTION, LEFT;

EID: 0032145919     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00116-3     Document Type: Article

References (36)

1. [1] Forman MB, Kolodgie FD, Jenkins M, Virmani R. Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications. J Am Coll Cardiol 1993;21:1245-1253.
2. [2] Tsao PS, Aoki N, Lefer DJ, Johnson III G, Lefer AM. Timecourse of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 1990;82:1402-1412.
3. [3] Entman ML, Michael L, Rossen RD, et al. Inflammation in the course of early myocardial ischemia. FASEB J 1991;5:2529-2537.
4. [4] Engler RL, Schmid-Schonbein GW, Pavlec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983;111:98-111.
5. [5] Lefer AM, Tsao PS, Lefer DJ, Ma X-L. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 1991;5:2029-2034.
6. [6] Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
7. [7] Buerke M, Weyrich AS, Lefer AM. Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil released mediators. Am J Physiol 1994;266:H128-H136.
8. [8] Ma X-L, Lefer DJ, Lefer AM, Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 1992;86:937-946.
9. [9] Romson JL, Hook BGF, Kunkel SL, et al. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983;67:1016-1023.
10. [10] Weyrich AS, Ma X-L, Lefer DJ, Albertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993;91:2620-2629.
11. [11] Lefer AM, Weyrich AS, Buerke M. Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc Res 1994;28:289-294.
12. [12] Hakomori S. Glycosphingolipids in cellular interaction, differentiation and oncogenesis. Annu Rev Biochem 1981;50:733-764.
13. [13] Hannun YA, Bell RM. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 1989;243:500-507.
14. [14] Endo K, Igarashi Y, Nisar M, Zhou Q, Hakomori S. Cell membrane signaling as target in cancer therapy: inhibitory effect of N,N-dimethyl and N,N,N-trimethyl sphingosine derivatives on in vitro and in vivo growth of tumor cells in nude mice. Cancer Res 1991;51:1613-1618.
15. [15] Kimura S, Kawa S, Ruan F, et al. Effect of sphingosine and its N-methyl derivatives on oxidative burst, phagokinetic activity, and trans-endothelial migration of human neutrophils. Biochem Pharmacol 1992;44:1585-1595.
16. [16] Okoshi H, Hakomori S, Nisar M, et al. Cell membrane signaling as target in cancer therapy. II: inhibitory effect of N,N,N-trimethylsphingosine on metastatic potential of murine B16 melanoma cell line through blocking of tumor cell-dependent platelet aggregation. Cancer Res 1991;51:6019-6024.
17. [17] Murohara T, Buerke M, Margiotta J, et al. Myocardial and endothelial protection by TMS in ischemia-reperfusion injury. Am J Physiol 1995;269:H504-H514.
18. [18] Pabla R, Buda AJ, Flynn DM, et al. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ Res 1996;78:65-72.
19. [19] Lefer DJ, Scalia R, Campbell B, et al. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 1997;99:684-691.
20. [20] Williams Jr. JH, Moser KM, Ulich T, Cairo MS. Harvesting the circulating pool of polymorphonuclear leukocytes by hetastarch exchange transfusion (HET): Yield and function assessment. J Leuko Biol 1987;42:455-462.
21. [21] Scalia R, Murohara T, Delyani JA, Nossuli TO, Lefer AM. Myocardial protection by N,N,N-trimethylsphingosine in ischemia reperfusion injury is mediated by inhibition of P-selectin. J Leuk Biol 1996;59:317-324.
22. [22] Mullane KM, Kramer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985;4:157-167.
23. [23] Bradley PP, Priebat DS, Christensen RD, Rothstein GR. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Clin Invest 1985;76:1713-1719.
24. [24] Weyrich AS, Ma XL, Buerke M, et al. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res 1994;75:692-700.
25. [25] Engler RL, Dahlgren MD, Morris DD, Paterson MA, SchmidSchönbein AW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1986;251:H314-H323.
26. [26] Entman L M, Smith CW. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res 1994;28:1301-1311.
27. [27] Smedly LA, Tonnesen MG, Sandhaus RA, et al. Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 1986;77:1233-1243.
28. [28] Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67:1033-1036.
29. [29] Kishimoto TK, Jutila MA, Butcher EC. Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc Natl Acad Sci USA 1990;87:2244-2248.
30. [30] Vaporciyan A, DeLisser A, Yan HM, et al. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 1993;262:1580-1582.
31. [31] Rubanyi GM, Vanhoutte PM. Oxygen derived free radicals, endothelium and responsiveness of vascular smooth muscle. Am J Physiol 1986;250:H815-H821.
32. [32] Geng JG, Bevilacqua MP, Moore KL, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990;343:757-760.
33. [33] Larsen E, Celi A, Gilbert GE, et al. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989;59:305-312.
34. [34] Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelialderived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 1994;107:1050-1058.
35. [35] Lefer AM, Lefer DJ. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol 1994;33:71-90.
36. [36] Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-4655.